Satoshi Matsusaka

3.4k total citations
133 papers, 1.5k citations indexed

About

Satoshi Matsusaka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Satoshi Matsusaka has authored 133 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 49 papers in Pulmonary and Respiratory Medicine and 24 papers in Pathology and Forensic Medicine. Recurrent topics in Satoshi Matsusaka's work include Colorectal Cancer Treatments and Studies (61 papers), Gastric Cancer Management and Outcomes (33 papers) and Cancer Treatment and Pharmacology (27 papers). Satoshi Matsusaka is often cited by papers focused on Colorectal Cancer Treatments and Studies (61 papers), Gastric Cancer Management and Outcomes (33 papers) and Cancer Treatment and Pharmacology (27 papers). Satoshi Matsusaka collaborates with scholars based in Japan, United States and Germany. Satoshi Matsusaka's co-authors include Nobuyuki Mizunuma, Mitsukuni Suenaga, Eiji Shinozaki, Kiyohiko Hatake, Yasuhito Terui, Yuji Mishima, Ichiro Wakabayashi, Heinz‐Josef Lenz, Mariko Ogura and Toshiharu Yamaguchi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Satoshi Matsusaka

122 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Matsusaka Japan 23 814 371 334 298 262 133 1.5k
Thomas Krahn Germany 18 593 0.7× 215 0.6× 380 1.1× 340 1.1× 140 0.5× 45 1.6k
Paolo D’Amico Italy 17 465 0.6× 254 0.7× 305 0.9× 352 1.2× 332 1.3× 55 1.4k
Klaus J. Schmitz Germany 22 401 0.5× 261 0.7× 297 0.9× 514 1.7× 425 1.6× 51 1.4k
Nobuaki Hiraoka Japan 17 510 0.6× 150 0.4× 670 2.0× 601 2.0× 292 1.1× 21 1.6k
Yao Yu United States 22 393 0.5× 360 1.0× 460 1.4× 605 2.0× 352 1.3× 138 1.8k
Alex Gordon‐Weeks United Kingdom 22 1.1k 1.4× 348 0.9× 377 1.1× 675 2.3× 434 1.7× 53 2.3k
Chun‐Ming Huang Taiwan 23 796 1.0× 308 0.8× 171 0.5× 485 1.6× 502 1.9× 58 1.7k
JiHoon Kang South Korea 21 493 0.6× 275 0.7× 476 1.4× 642 2.2× 133 0.5× 63 1.4k
Thibault Mazard France 19 1.0k 1.3× 400 1.1× 863 2.6× 570 1.9× 218 0.8× 90 1.8k

Countries citing papers authored by Satoshi Matsusaka

Since Specialization
Citations

This map shows the geographic impact of Satoshi Matsusaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Matsusaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Matsusaka more than expected).

Fields of papers citing papers by Satoshi Matsusaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Matsusaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Matsusaka. The network helps show where Satoshi Matsusaka may publish in the future.

Co-authorship network of co-authors of Satoshi Matsusaka

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Matsusaka. A scholar is included among the top collaborators of Satoshi Matsusaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Matsusaka. Satoshi Matsusaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Makita, Shuichi, et al.. (2024). Label-free visualization and quantification of the drug-type-dependent response of tumor spheroids by dynamic optical coherence tomography. Scientific Reports. 14(1). 3366–3366. 14 indexed citations
3.
Mori, Tomoko, et al.. (2023). Culture of circulating tumor cells using a microfilter device. Oncology Reports. 49(5). 2 indexed citations
4.
Makita, Shuichi, Pradipta Mukherjee, Antonia Lichtenegger, et al.. (2023). Theoretical model for en face optical coherence tomography imaging and its application to volumetric differential contrast imaging. Biomedical Optics Express. 14(7). 3100–3100. 8 indexed citations
5.
Matsumura, Hiroki, Akihiro Isozaki, Hideharu Mikami, et al.. (2023). Virtual-freezing fluorescence imaging flow cytometry with 5-aminolevulinic acid stimulation and antibody labeling for detecting all forms of circulating tumor cells. Lab on a Chip. 23(6). 1561–1575. 8 indexed citations
6.
Miyazawa, Arata, Shuichi Makita, Pradipta Mukherjee, et al.. (2021). Three-dimensional dynamics optical coherence tomography for tumor spheroid evaluation. Biomedical Optics Express. 12(11). 6844–6844. 46 indexed citations
7.
Yanagitani, Noriko, Kanako Suga, Takahiro Yoshizawa, et al.. (2020). A Novel System to Detect Circulating Tumor Cells Using Two Different Size-selective Microfilters. Anticancer Research. 40(10). 5577–5582. 4 indexed citations
8.
Hanna, Diana L., Fotios Loupakis, Dongyun Yang, et al.. (2018). Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. Clinical Colorectal Cancer. 17(3). e471–e488. 8 indexed citations
9.
Mishima, Yuji, Satoshi Matsusaka, Keisho Chìn, et al.. (2017). Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients. Targeted Oncology. 12(3). 341–351. 38 indexed citations
10.
Berger, Martin D., Sebastian Stintzing, Volker Heinemann, et al.. (2017). A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab. Clinical Cancer Research. 24(4). 784–793. 21 indexed citations
11.
Matsusaka, Satoshi, Wu Zhang, Shu Cao, et al.. (2016). TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy. Molecular Cancer Therapeutics. 15(6). 1405–1411. 11 indexed citations
12.
Stremitzer, Stefan, Wu Zhang, Dongyun Yang, et al.. (2016). Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection. Molecular Cancer Therapeutics. 15(11). 2814–2821. 8 indexed citations
13.
Matsusaka, Satoshi, Diana L. Hanna, Shu Cao, et al.. (2016). Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy. Clinical Cancer Research. 22(13). 3218–3226. 23 indexed citations
14.
Ning, Yan, Diana L. Hanna, Wu Zhang, et al.. (2015). Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach. Molecular Cancer Therapeutics. 14(10). 2401–2408. 22 indexed citations
15.
Stintzing, Sebastian, Wu Zhang, Volker Heinemann, et al.. (2015). Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer. Molecular Cancer Therapeutics. 14(10). 2374–2381. 5 indexed citations
16.
Suzuki, Shunichi, Satoshi Matsusaka, Mitsuharu Hirai, et al.. (2015). A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction. International Journal of Oncology. 47(1). 97–105. 5 indexed citations
17.
Mishima, Yuji, Yasuhito Terui, Yuko Mishima, et al.. (2012). High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism. International Immunology. 24(8). 477–483. 28 indexed citations
18.
Kuboki, Yasutoshi, Nobuyuki Mizunuma, Masato Ozaka, et al.. (2011). Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer. Oncology Letters. 2(3). 493–498. 10 indexed citations
19.
Yokokawa, Takashi, Kazuyoshi Kawakami, Eiji Shinozaki, et al.. (2011). Usefulness of Pharmaceutical Outpatient Clinic in XELOX Therapy. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 37(11). 611–615. 15 indexed citations
20.
Kanazawa, Hidenori, et al.. (1986). Measurement of azygos blood flow by a continuous thermodilution method in liver disease.. Kanzo. 27(8). 1132–1140. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Krahn Breakdown of academic impact, for papers by Paolo D’Amico Breakdown of academic impact, for papers by Klaus J. Schmitz Breakdown of academic impact, for papers by Nobuaki Hiraoka Breakdown of academic impact, for papers by Yao Yu Breakdown of academic impact, for papers by Alex Gordon‐Weeks Breakdown of academic impact, for papers by Chun‐Ming Huang Breakdown of academic impact, for papers by JiHoon Kang Breakdown of academic impact, for papers by Thibault Mazard
Rankless by CCL
2026